ARCHIVES

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

NCI To Boost Investigator-Initiated Grants Using 5.7% Increase, Cuts In Contracts

February 9, 1996

Emory Cancer Experiment Launched Into Space

January 17, 2003

Degarelix Active In Phase II Trial In Prostate Cancer

October 29, 2004

In Brief: Changes In Key Subcommittee chairmanships, Brooke’s Defeat Leave Direction In Doubt

November 17, 1978

Hrushesky To Pursue Chronobiology Work At Albany, Forms Group

April 28, 1989

GOP Sweep Takes Out Two Old Friends, But Reagan Spoken say He Supports Cancer Program, NIH

November 14, 1980